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Abstract
Deletion of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) envelope (E) gene attenuates the virus. E gene
encodes a small multifunctional protein that possesses ion channel (IC) activity, an important function in virus-host
interaction. To test the contribution of E protein IC activity in virus pathogenesis, two recombinant mouse-adapted SARS-
CoVs, each containing one single amino acid mutation that suppressed ion conductivity, were engineered. After serial
infections, mutant viruses, in general, incorporated compensatory mutations within E gene that rendered active ion
channels. Furthermore, IC activity conferred better fitness in competition assays, suggesting that ion conductivity represents
an advantage for the virus. Interestingly, mice infected with viruses displaying E protein IC activity, either with the wild-type
E protein sequence or with the revertants that restored ion transport, rapidly lost weight and died. In contrast, mice infected
with mutants lacking IC activity, which did not incorporate mutations within E gene during the experiment, recovered from
disease and most survived. Knocking down E protein IC activity did not significantly affect virus growth in infected mice but
decreased edema accumulation, the major determinant of acute respiratory distress syndrome (ARDS) leading to death.
Reduced edema correlated with lung epithelia integrity and proper localization of Na+/K+ ATPase, which participates in
edema resolution. Levels of inflammasome-activated IL-1b were reduced in the lung airways of the animals infected with
viruses lacking E protein IC activity, indicating that E protein IC function is required for inflammasome activation. Reduction
of IL-1b was accompanied by diminished amounts of TNF and IL-6 in the absence of E protein ion conductivity. All these key
cytokines promote the progression of lung damage and ARDS pathology. In conclusion, E protein IC activity represents a
new determinant for SARS-CoV virulence.
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Introduction
Coronaviruses (CoVs) are vertebrate pathogens that cause
severe diseases in a wide range of animals and infections in
humans that until recently were limited to common colds [1].
Nevertheless, by the end of 2002, a novel coronavirus causing
the severe acute respiratory syndrome (SARS-CoV) emerged in
China and rapidly spread worldwide causing around 8000
infections leading to death in 10% of the cases [2,3]. Since then,
CoVs surveillance programs were intensified, and two additional
human coronaviruses, already circulating in the human popula-
tion, were identified as the causative agents of several cases of
pneumonia and bronchiolitis (HCoV-HKU1 and HCoV-NL63)
[4]. Furthermore, in 2012 a novel coronavirus infecting humans,
the Middle East Respiratory Syndrome Coronavirus (MERS-
CoV) appeared in Saudi Arabia and disseminated to nine
additional countries [5,6]. To date, 182 cases of MERS-CoV
have been reported, which has led to 79 fatalities (http://www.
who.int). Clinical presentation of infected individuals involves
acute pneumonia, sometimes accompanied by renal disease [7].
CoVs similar to SARS-CoV and MERS-CoV have also been
isolated from bats widely distributed throughout the world [8–13],
which represents a potential reservoir for outbreaks of novel
zoonoses into humans. Therefore, understanding the virulence
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mechanisms of these pathogens, will allow the development of
effective therapies in order to prevent and control future
outbreaks.
SARS-CoV is an enveloped virus containing a positive sense
RNA genome of 29.7 kb, one of the largest viral RNA genomes
known. The genome encodes a viral replicase involved in the
synthesis of new genomes and in the generation of a nested set of
subgenomic messenger RNAs, encoding both structural proteins
present in all CoVs: Spike (S), Envelope (E), Membrane (M) and
Nucleoprotein (N), and a group of proteins specific for SARS-
CoV: 3a, 3b, 6, 7a, 7b, 8a, 8b, and 9b [14].
SARS-CoV E protein is a 76-amino acid transmembrane
protein actively synthesized during viral infection, that mainly
localizes at the ERGIC region of the cell, where virus budding and
morphogenesis take place [15–18]. Different requirements of E
protein during the virus cycle have been described among CoVs.
Elimination of E gene in transmissible gastroenteritis coronavirus
(TGEV) or MERS-CoV leads to a replication-competent propa-
gation-deficient phenotype [19–21]. In contrast, deletion of E gene
from mouse hepatitis virus (MHV) or SARS-CoV does not abolish
virus production, although viral titers are significantly reduced by
1000 to 20-fold, respectively [16,22]. Interestingly, E gene deleted
SARS-CoV (SARS-CoV-DE) was attenuated in three animal
models, and confers protection against challenge with parental
virus in immunized hamsters, and in young or aged mice,
representing a promising vaccine candidate [16,23–27]. Cells
infected with SARS-CoV-DE show increased stress and apoptotic
markers compared to wild type virus, perhaps resulting in a
decreased productivity of infection [28]. Additionally, elimination
of the E gene diminishes inflammation induced by SARS-CoV
through the NF-kB pathway [27].
Remarkably, SARS-CoV E protein was found to self-interact
forming a pentameric structure that delimits an ion conductive
pore, which may play a role in virus-host interaction [29–32]. E
protein ion conductivity was also confirmed for a set of CoVs from
different genera [33]. The ion channel (IC) activity of SARS-CoV
E protein was mapped within the transmembrane domain of the
protein by using synthetic peptides [31,34,35]. Recent studies
determined that both ion conductance and selectivity of E protein
ion channel were highly controlled by the charge of the lipid
membranes in which the pores were assembled. This suggests that
lipid head-groups are components of the channel structure facing
the lumen of the pore, a novel concept for CoV E protein ion
channel [34,36]. Chemically synthesized SARS-CoV E protein
showed slight preference for cations over anions when reconsti-
tuted in lipids that mimicked both charge and composition of
ERGIC membranes, and displayed no specific selectivity for a
particular cation [34,36]. In addition, point mutations that
suppressed SARS-CoV E protein IC activity (N15A and V25F)
have been identified and confirmed [34,35].
Several reports have analyzed the relevance of CoV E protein
transmembrane domain, which contains ion-conduction proper-
ties, in virus maturation and production. Insertion of alanine
residues within the transmembrane domain of MHV E protein
rendered crippled viruses that evolutionary reverted to restore a
proper structure of the alpha helix within the transmembrane
domain [37]. Interchanging the genus b CoV MHV E protein
transmembrane domain by those of CoVs from different genera
revealed that only domains belonging to genus b, and c, but not a,
functionally replaced MHV E transmembrane domain in terms of
viral production. It was speculated that this effect was a
consequence of the possible different ion selectivity of these
domains [38]. Replacement of genus c CoV infectious bronchitis
virus (IBV) E protein transmembrane domain, which displays IC
activity, for vesicular stomatitis virus (VSV) G protein transmem-
brane domain lacking this function, interfered with an efficient
trafficking and release of the viral progeny in the infected cells
[39]. In contrast, mutation of threonine at position 16 to alanine,
which is the amino acid change predicted to inhibit IC activity in
IBV E protein did not affect virus-like particles formation,
suggesting a multifunctional role of E protein [40].
Besides the E protein, SARS-CoV encodes two other ion-
conducting proteins, 3a and 8a [41,42]. In a related virus, human
coronavirus 229E (HCoV-229E), novel IC activity has been
described within the 4a protein [43]. The abundance and
conservation of IC activity suggests an importance of influencing
ion homeostasis within cells during the CoV infection cycle.
Modulation of the cellular ion balance seems to be a common
issue for viruses, as a growing list of viroporins are being identified,
especially within RNA viruses [44]. Highly pathogenic human
viruses such as influenza A virus, human immunodeficiency virus
(HIV), hepatitis C virus (HCV) and several picornaviruses, among
others, encode at least one viroporin [45–49]. Viroporins have
been involved in virus entry, trafficking, morphogenesis, matura-
tion and even virulence [50–53]. Influenza virus M2 is essential for
viral RNA release from infections virions within the endosome into
the cell cytoplasm [45] and also for raising the pH at the trans-
Golgi network lumen, which prevents premature activation of
hemaglutinin, which may render non-infectious virions [54].
Similarly, HCV p7 protein equilibrates the pH at the Golgi
apparatus, protecting acid-sensitive intracellular virions [51].
Coxsackievirus 2B protein alters Golgi and endoplasmic reticulum
(ER) Ca2+ and H+ concentrations, which in turn delay protein
transport through the secretory pathway facilitating virus assembly
and preventing major histocompatibility complex (MHC) mole-
cules from reaching the cell surface [48,55,56]. A recent finding
described that influenza M2 protein IC activity triggers NOD-like
receptor family, pyrin domain containing 3 (NLRP3) inflamma-
some activation [52]. Furthermore, mutant versions of M2 protein
that conduct Na+ and K+ ions apart from H+ ions more strongly
elicited the inflammasome response [52]. This novel mechanism of
Author Summary
Several highly pathogenic viruses encode small transmem-
brane proteins with ion-conduction properties named
viroporins. Viroporins are generally involved in virus
production and maturation processes, which many times
are achieved by altering the ion homeostasis of cell
organelles. Cells have evolved mechanisms to sense these
imbalances in ion concentrations as a danger signal, and
consequently trigger the innate immune system. Recently,
it has been demonstrated that viroporins are inducers of
cytosolic macromolecular complexes named inflamma-
somes that trigger the activation of key inflammatory
cytokines such as IL-1b. The repercussions of this system in
viral pathogenesis or disease outcome are currently being
explored. SARS-CoV infection induces an uncontrolled
inflammatory response leading to pulmonary damage,
edema accumulation, severe hypoxemia and eventually
death. In this study, we report that SARS-CoV E protein ion
channel activity is a determinant of virulence, as the
elimination of this function attenuated the virus, reducing
the harmful inflammatory cytokine burst produced after
infection, in which inflammasome activation plays a critical
role. This led to less pulmonary damage and to disease
resolution. These novel findings may be of relevance for
other viral infections and can possibly be translated in
order to find therapies for their associated diseases.
SARS-CoV Ion Channel Activity and Pathogenesis
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immune system activation has also been proven for other
viroporins [53,57–59].
Viral proteins with IC activity impact different aspects of the
virus life cycle, however, the involvement of their IC activity in
pathogenesis remain to be further explored. Previous findings
demonstrated that SARS-CoV E protein is a virulence determi-
nant. In this manuscript we analyze the contribution of E protein
IC activity in pathogenesis. Two recombinant viruses, each one
containing a single point mutation suppressing IC activity, were
generated by reverse genetics. Mutant viruses showed a tendency
to evolve and restore E protein IC architecture and activity after
serial infections, and viruses with deficient IC activity were
outcompeted by those displaying this function after co-infections.
This highlights the importance of IC activity in virus fitness.
Interestingly, infection of mice with a set of viruses lacking or
displaying E protein IC activity, revealed that the activation of
inflammasome pathway, and the exacerbated inflammatory
response induced by SARS-CoV was decreased in infections by
on channel deficient viruses. In addition, less lung damage and
proper localization of Na+/K+ ATPase within epithelia, which
prevents edema accumulation, was detected for the mice infected
with the viruses lacking E protein IC activity. As a consequence,
increased survival of the infected animals was observed when E
protein ion conductivity was absent. Therefore, E protein IC
activity is required for inflammasome activation and a novel
determinant for the virulence of highly pathogenic SARS-CoV.
Results
SARS-CoV E protein IC activity is not essential for virus
production in cell culture
Deletion of SARS-CoV E gene resulted in a virus that was
attenuated in three animal models, as we have previously shown
[16,23,24,26,27]. E gene codes for the small multifunctional E
protein, which displays IC activity [31,34–36]. To specifically test
the relevance of IC activity in virus virulence, residues involved in
E protein ion conductance were firstly identified. To this end a set
of synthetic peptides representing the transmembrane domain of E
protein were evaluated for their IC activity. These peptides
contained point mutations that affect different conserved residues,
or residues predicted to face the lumen of the channel pore [34].
Mutations N15A and V25F within the transmembrane domain of
E protein completely disrupted IC activity [34,35]. Accordingly,
two recombinant viruses containing each of these two changes in
the E gene, rSARS-CoV-E-N15A (N15A) and rSARS-CoV-E-
V25F (V25F), were engineered (Fig. 1). A SARS-CoV with a
mouse adapted (MA15) genetic background [27,60] was used to
generate these viruses, as infection of mice with SARS-CoV MA15
accurately reproduces the symptoms of human disease [27,60].
The mutant viruses were efficiently rescued, cloned by three
rounds of plaque purification, and their sequence was confirmed
(data not shown). To test whether the introduced mutations may
alter E protein subcellular localization affecting other functions of
the protein, Vero E6 cells were infected with the wt virus, the
viruses lacking IC activity (N15A and V25F) or a virus missing E
gene (DE) as a control. Immunofluorescence analysis showed
similar colocalization patterns of E protein and ERGIC, the
subcellular compartment where E protein mainly accumulates
during infection, for both the wt and the mutant viruses (Fig. 2A),
indicating that other functions of E protein associated with its
localization are most likely not affected.
Deletions or mutations within the E gene of several CoVs
sometimes led to crippled viruses or to lower virus yields [16,20–
22,37,39]. To test whether inhibition of E protein IC activity
affects virus production, growth kinetics were performed in the
monkey Vero E6 and mouse DBT-mACE2 cells [61]. Minor
differences in growth rates were observed between the parental
virus (wt), that contains E protein IC activity, and the mutant
viruses that lack E protein IC activity (Fig. 2B), indicating that this
function was not essential for virus growth in cell culture. More
striking differences in plaque phenotypes were observed. Mutant
viruses lacking E protein IC activity, apparently formed smaller
plaques than wt virus, and V25F virus plaques were smaller than
N15A virus (Fig. 2C). A possible explanation for all these data
could be that infection foci productivity and area may be quite
similar regardless of E protein IC activity, as determined by viral
titration, but higher cytopathic effect may be induced when E
protein IC is present, rendering bigger plaques. Elimination of full-
length E protein induced more severe growth defects (Fig. 2B
and Fig. 2C), suggesting that other functions of the protein
contributing to virus production, apart from IC activity, may be
affected.
SARS-CoV E protein IC activity improves viral fitness
Inhibition of E protein IC activity slightly reduced virus
production in cell culture in a relatively short period of time, but
these differences were not significant. To further explore whether
ion conductivity could improve viral growth and fitness, a long-
term competition assay was performed between the wt virus and
the N15A mutant lacking IC activity, that was relative stable
through passages as will be described below. Vero E6 cells were
co-infected with N15A mutant and the wt virus in a proportion
7:3, and the supernatant was serially passaged for 20 times every
24 hours. The E gene was sequenced every 4 passages, revealing
that the proportion of wt virus steadily increased over the passages,
accompanied by a decrease in the abundance of the N15A mutant.
From passage 8 on, the wt virus took and maintained majority
over the N15A mutant (Fig. 3). These results suggested that E
protein IC activity for SARS-CoV confers a selective advantage
improving virus production.
SARS-CoV E protein IC activity confers virulence in vivo
To specifically analyze the contribution of E protein IC activity
to SARS-CoV virulence, BALB/c mice were intranasally inocu-
lated with the wt virus displaying E protein IC activity, or three
independently-isolated clones of the mutant viruses N15A and
V25F lacking E protein IC activity, and mice were monitored
daily for 10 days (n = 5/virus clone). All infected animals showed
disease symptoms at 2 days post infection (dpi), reflected by slower
movements and ruffled fur (data not shown). Mice infected with
the wt virus started to lose weight by day 2, and by day 5 all of
them died (Fig. 4). Interestingly, although mice infected with the
three clones of N15A mutant started to lose weight in a similar
fashion, at day 4 almost all of them started to regain weight,
recover from the disease, and 80–100% survived (Fig. 4). In
contrast to N15A, mice infected with V25F virus experimented
similar weight losses and survival rates (from 0 to 20%) than the wt
virus (Fig. 4). A possible explanation for this apparent discrepancy
was the reversion of the introduced mutation or the incorporation
of compensatory mutations restoring E protein IC activity. To test
whether this was the case, total RNA was collected from the lungs
of infected mice at 2 and 4 dpi or from the lungs of mice that died
after infection. The virus genome region containing E gene was
sequenced, as it was the target of the point mutations inhibiting IC
activity, and therefore a likely place to incorporate compensatory
mutations. E genes from wt virus and N15A mutant virus
remained stable during the course of the experiment, since no
changes were found in viral RNA extracted either from lungs of
SARS-CoV Ion Channel Activity and Pathogenesis
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several mice at 2 and 4 dpi or from dead mice (Fig. 5A). In
contrast, V25F viruses incorporated mutations in the E gene
that led to amino acid changes either in the same position of the
mutation that abolished IC activity (F25C) or in relatively close
positions within the E protein transmembrane domain: L19A,
F20L, F26L, L27S, T30I and L37R (Fig. 5A). These evolved
variants of the V25F virus appeared as early as 2 days after mice
infection and, in some cases (T30I mutant), completely overgrew
the original virus by day 2. The tentative compensatory mutations
were also present in the viral population at 4 dpi and in dead mice
(Fig. 5A). Overall, the data obtained with wt and N15A viruses,
which were genetically stable throughout the experiment, suggest
that E protein IC activity is required for a virulent phenotype.
Viruses missing E protein IC activity are prone to evolve
and restore ion conductivity
To further analyze the evolution of the mutant viruses lacking E
protein IC activity, two clones of the mutants N15A and V25F
were serially passaged in cell culture. Throughout the 24 serial
passages, E gene was sequenced at passages 0, 8, 16 and 24 for the
two mutant viruses and wt as control. As observed during in vivo
infection, the wt virus remained stable during the passages
(Fig. 5B). V25F viruses rapidly incorporated additional mutations
within E gene (L19A, L27S and T30I), reproducing our in vivo
observations. The viruses incorporating T30I mutation completely
out-competed the original V25F mutant by passage 8 (Fig. 5B). In
contrast, N15A viruses either remained stable or incorporated a
mutation in the E gene (A15D) that appeared late, at passage 24,
suggesting that this mutant was more stable, confirming our in vivo
results (Fig. 5B). The data obtained in cell culture or after mice
infection indicate that SARS-CoVs lacking E protein IC activity
incorporated mutations at the E gene that directly reverted the
original mutation that suppressed IC activity (A15D and F25C) or
modified residues mapping to a close position of the E protein
transmembrane domain. These modified residues face the original
mutation inhibiting IC activity, when the ion channel is assembled
(Fig. 6). To analyze whether these mutations restored IC activity,
synthetic peptides representing the E protein transmembrane
domain containing the mutations obtained after viral evolution in
vivo and in cell culture (N15D, V25L, V25F L19A, V25F F26C,
V25F L27S, V25F T30I, V25F L37R), were synthesized. The
IC activity of these peptides was evaluated in artificial lipid
membranes as previously described [34]. Whereas peptides
containing the original mutations N15A and V25F did not show
Figure 1. Engineering of rSARS-CoVs lacking E protein ion channel (IC) activity. SARS-CoV genome is represented at the top, and the
region expanded shows wild type SARS-CoV E protein sequence (wt) and its different domains: amino terminal (N-terminal), transmembrane (TMD)
and carboxy terminal (C-terminal). To generate viruses lacking E protein ion channel activity (rSARS-CoV-EIC2) the amino acid changes N15A or V25F
were introduced within viral genome to generate two recombinant viruses. The positions of the mutated residues within the transmembrane domain
of a simplified E protein oligomer inserted in a lipid membrane are shown at the bottom.
doi:10.1371/journal.ppat.1004077.g001
SARS-CoV Ion Channel Activity and Pathogenesis
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Figure 2. Subcellular localization of rSARS-CoV-EIC2 E proteins, growth kinetics and plaque size. (A) Vero E6 cells were infected either
with the mutant viruses (N15A and V25F), the parental virus (wt) or a virus lacking E gene (DE) at an MOI of 0.3, fixed at 24 hpi and E protein (green)
and ERGIC (red) were labeled with specific antibodies. Nuclei were stained with DAPI (blue). Original magnification was 1266. Right graphic on the
panel represents the percentage of colocalization between E protein and ERGIC, calculated with Leica LAS AF v2.6.0 software. (B) Vero E6 and DBT-
mACE2 cells were infected at an MOI of 0.001 with mutant viruses lacking IC activity (N15A and V25F), the parental virus (wt) or a virus lacking E gene
(DE), and viral progeny was titrated at the indicated times post-infection. Error bars represent the standard deviation of three independent
experiments. (C) Plaque morphology of the parental, the mutant viruses N15A and V25F and a DE virus.
doi:10.1371/journal.ppat.1004077.g002
SARS-CoV Ion Channel Activity and Pathogenesis
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any conductance, all the peptides containing the mutations
obtained after viral evolution displayed similar conductance values
than a wild type peptide (Fig. 7), indicating that all these
compensatory mutations restored E protein IC activity.
Genetically engineered revertant viruses restoring E
protein IC activity show a virulent phenotype in mice
A correlation between IC activity and virulence was found in
vivo, where N15A viruses lacking IC activity were attenuated
compared to wt virus competent in IC activity. Mutant virus
V25F, originally lacking ion conductivity, rapidly incorporated
compensatory mutations upon infection in vivo that restored IC
activity and thus caused pathogenicity. To test whether the
recovery of IC activity was the unique determinant of virulence,
and to rule out effects of other mutations arising outside of the E
gene, recombinant viruses containing a set of the compensatory
mutations that restored IC activity (rSARS-CoV-EICrev): rSARS-
CoV-E-V25F L27S (V25F L27S), rSARS-CoV-E-V25F T30I
(V25F T30I), rSARS-CoV-E-V25F L37R (V25F L37R) were
engineered, rescued and tested in mice. These viruses were
Figure 3. Effect of SARS-CoV E protein IC activity on viral fitness. Competition assays between the parental virus (wt, black circles) displaying
IC activity (EIC+) and a mutant virus (N15A, red squares) lacking IC activity (EIC2) were performed. Vero E6 cells were co-infected with mutant and
parental viruses at a ratio 7:3 and supernatants were serially passaged 20 times every 24 hours. Relative abundance of each virus was determined by
sequencing E gene within viral progeny. Error bars represent the standard deviation from three independent experiments.
doi:10.1371/journal.ppat.1004077.g003
Figure 4. Pathogenesis caused by rSARS-CoV-EIC2 in BALB/c mice. Groups of five 16 week-old BALB/c mice were mock infected (Mock,
green circles) or infected with 100000 PFU of either the parental virus (wt, black circles) or several clones of the mutant viruses missing IC activity:
N15A C1, N15A C2 and N15A C3 (red, orange and deep-red squares, respectively), and V25F C1, V25F C2 and V25F C3 (dark blue, blue and light blue
triangles, respectively). Mean weight losses (left graph) and survival (right graph) during 10 days following infection are represented for each group.
Error bars represent the standard deviation for mice weights per experimental condition.
doi:10.1371/journal.ppat.1004077.g004
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Figure 5. Stability of rSARS-CoV-EIC2 after serial infections. (A) Groups of eleven 16 week-old BALB/c mice were infected with 100000 PFU of
either the parental virus (wt) or three clones of the mutant viruses missing IC activity: N15A C1, N15A C2, N15A C3, V25F C1, V25F C2 and V25F C3. At
2 dpi and 4 dpi 3 mice of each group were sacrificed, lung RNA was extracted, and E gene was sequenced. The rest of the mice (5 per group)
participated in the weight-loss and survival experiment. When any mouse died, from 4 to 10 dpi, lung RNA was extracted and E gene was sequenced.
Bars represent different E protein sequences, either that of parental or the mutant viruses. The central colored part represents the transmembrane
domain of the protein. Letters and numbers in red represent the amino acid changes detected after viral evolution and their relative position within
transmembrane domain, respectively. Numbers accompanying bars indicate from how many mice (first number) out of the total of the animals
analyzed (second number) arose the indicated sequence change. Dead mice are indicated by a {. (B) Vero E6 cells were infected with the wt virus or
the mutant clones N15A C1 and N15A C2, V25F C1 and V25F C2 at an initial MOI of 0.5, and supernatants were serially passaged for 24 times every
24 hours. E gene in the viral population was sequenced at passages 0, 8, 16 and 24. Colored bars represent the transmembrane domain of different E
protein sequences and letters and numbers in red represent the amino acid mutations identified and their relative position, respectively.
doi:10.1371/journal.ppat.1004077.g005
SARS-CoV Ion Channel Activity and Pathogenesis
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Figure 6. Spatial distribution of the mutations obtained in rSARS-CoV-EIC2 after serial infections. (A) Left diagram represents a top view
of E protein transmembrane domain and the spatial distribution of the amino acids within the alpha helix. Blue and red circles correspond to amino
acids N15 and V25, respectively, originally mutated to inhibit IC activity. Yellow circles surround the amino acids that changed after evolution of V25F
mutant. Arrow at position 15 points the lumen of the ion channel pore. Right graphic depicts the pentamer conformation of E protein that forms the
ion conductive pore and the positions of both the mutated residue at position 25 and the evolved mutations at positions 19, 25, 26, 27, 30 and 37.
Evolved changes map close to the originally mutated residue in the monomer-monomer interface. (B) Pentameric model of SARS-CoV E protein from
a lateral (left) or a top view (right). This model was first proposed from linear dichroism of isotopically labeled E protein transmembrane peptides in
lipid bilayers [29,32]. The residues involved in ion channel inhibition (N15 in blue and V25 in red) or mutated after viral evolution (L19, F26, L27, T30
and L37 in yellow) are highlighted.
doi:10.1371/journal.ppat.1004077.g006
SARS-CoV Ion Channel Activity and Pathogenesis
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virulent in mice in terms of weight loss and survival rates,
causing similar disease as that caused by the wt virus (Fig. 8).
We sought to confirm this data on another genetic back-
ground, so a recombinant SARS-CoV containing the mutation
that restored IC activity in N15A mutant after cell culture
passage was engineered rSARS-CoV-E-N15D (N15D) and
evaluated. In agreement with the V25F revertants, the mutant
N15D induced similar morbidity and mortality as wt (Fig. 8),
confirming that E protein IC activity is a determinant of virus
pathogenesis.
SARS-CoV E protein IC activity is dispensable for efficient
growth in vivo
Although E protein IC activity is not essential for virus growth
in cell culture (Fig. 2B), it is possible that production of virus in vivo
further depends on ion conductivity. To test if the attenuation
observed in vivo with IC inactive viruses is due to lower virus
production, 16 week-old BALB/c mice were intranasally inocu-
lated with the wt virus, the genetically engineered revertant viruses
N15D and V25F T30I displaying IC activity, or the N15A mutant
lacking IC activity. Mice lungs were collected at 2 and 4 days post
Figure 7. E protein IC activity of the rSARS-CoV-EIC2 evolved variants. Synthetic peptides representing E protein transmembrane domain of
the parental virus (wt) the mutant viruses (MUT) lacking IC activity (N15A and V25F) and their evolved revertants (REV) obtained after infections of
mice or cell culture (N15D, V25L, V25F L19A, V25F F26C, V25F L27S, V25F T30I and V25F L37R) were reconstituted in artificial lipid bilayers, and their IC
activity was analyzed as mean conductance values. Negative controls (C2) indicate conductance values obtained in the absence of any peptide. Error
bars represent the variations obtained in 100 independent experiments.
doi:10.1371/journal.ppat.1004077.g007
Figure 8. Pathogenesis caused by rSARS-CoV-EICrev in BALB/c mice. Groups of five 16 week-old BALB/c mice were mock infected (Mock,
green circles) or infected with 100000 PFU of either the parental virus (wt, black circles) or the genetically engineered revertant viruses recovering IC
activity: N15D (deep-red diamonds), V25F L27S (fuchsia triangles), V25F T30I (pink triangles) and V25F L37R (green triangles). Mean weight losses (left
graph) and survival (right graph) during 10 days are represented for each group. Error bars represent the standard deviation for mice weights per
experimental condition.
doi:10.1371/journal.ppat.1004077.g008
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infection, homogenized, and viral titers were determined. Inter-
estingly, the virus lacking IC activity (N15A) grew to the same
extent or even better than the wt and the revertant viruses,
respectively, reaching titers higher than 108 and 107 PFU/gr of
lung tissue at 2 and 4 dpi, respectively (Fig. 9). These data
indicate that E protein IC activity does not significantly affect virus
production in vivo, under these experimental conditions. Therefore
the attenuation of the virus lacking IC activity is likely due to a
host-specific effect mediated by the ion channel in the mouse, and
not to a reduction in virus yields.
Viruses with E protein IC activity induced edema
accumulation after SARS-CoV infection
To analyze the mechanisms by which IC inactivity confers less
virulence, lung sections of mock-infected mice, or of those infected
with the wt virus, IC revertants and N15A mutant were collected
at 2 and 4 dpi, stained with hematoxylin and eosin and examined
for histopathological changes. Mock-infected animals showed wide
free alveolar and bronchiolar airways and no evidence of leukocyte
infiltrates (Fig. 10A). Animals infected with the viruses displaying
IC activity, presented swollen alveoli walls and leukocyte infiltrates
in the infected areas at both time points (Fig. 10A). The
histopathology caused by IC proficient viruses was even more
dramatic at 4 dpi, where cell infiltrates were more abundant, and
air spaces were collapsed by a profuse lung edema, which is the
ultimate cause of acute respiratory distress syndrome (ARDS) that
leads to lung failure and death (Fig. 10A). Edema accumulation at
4 dpi was also reflected by a marked increase (.1.5 fold) in the
weight of lungs in animals infected with viruses competent in E
protein ion conductivity (Fig. 10B). In contrast, mice infected
with the virus lacking IC activity (N15A) showed moderate swollen
lung epithelia and lung infiltrates that reflected a productive viral
infection. However, at 4dpi, lung airways remained free from
pulmonary edema, reflected by both the lung sections and in the
minimal change of lung weight (Fig. 10A and 10B). Such
moderate changes in the lung may retain efficient oxygen
exchange. These data suggested that E protein IC activity
contributes to SARS-CoV induced lung edema.
SARS-CoV displaying E protein IC activity induces
disassembly of bronchoalveolar epithelia
ARDS caused by SARS-CoV infection originates from the
accumulation of a protein rich edema, leading to severe
hypoxemia and eventually to death. Lung epithelial cells create
an osmotic gradient between airways and lung interstitium
controlling water levels within air spaces. Damage to the
epithelium is therefore a major cause of edema accumulation.
To test the correlation between presence of E protein IC activity
and an increase in epithelial damage leading to edema accumu-
lation, lungs from mock-infected and from mice infected with the
wt or the N15A virus were processed at 2 and 4 dpi for
immunofluorescence. Epithelium integrity was evaluated using a
specific antibody for Na+/K+ ATPase, a key factor in establishing
the osmotic gradient necessary for edema clearance, and infection
was tracked using an antibody specific for N protein. At 2 dpi
many infected cells (around 16%) were observed in lungs of mice
infected with either wt or N15A virus (Fig. 11A and S1),
overlapping with the most productive time of viral infection. Both
Figure 9. Effects of SARS-CoV E protein IC activity on virus growth in BALB/c mice lungs. Groups of six 16 week-old BALB/c mice were
infected with 100000 PFU of viruses displaying E protein IC activity (EIC+), either the parental virus (wt, black columns) or the genetically engineered
revertant viruses V25F T30I (purple columns) and N15D (deep-red columns) or with the mutant lacking IC activity (EIC2) N15A (red columns). At 2 and
4 days post infection (dpi) 3 mice from each group were sacrificed to determine virus titers.
doi:10.1371/journal.ppat.1004077.g009
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viruses presented similar cell tropisms within lungs, infecting
bronchiolar epithelium (between 60–70% of the cells) and alveolar
epithelium (around 10% of the cells) (Fig. 11A and S1). Viral
infections caused cell death leading to desquamation, especially at
the bronchiolar barrier (Fig. 11A). At 4 dpi the number of
infected cells was dramatically reduced (close to 1%) (Fig. 11B
and S1), accompanying viral titer decrease. Interestingly, wt
infected mice showed abundant epithelia disassembly at this time
point, especially in the bronchioles. Na+/K+ ATPase was
mislocated from its basolateral position within the plasma
membrane of epithelial cells as a consequence of bronchiolar
barrier destruction, and detected in desquamated cells or cell
debris present at air spaces (Fig. 11B), where edema accumulation
was also observed (Fig. 10). The removal of Na+/K+ ATPase
from its native position within the epithelial barrier most likely
prevented its function in edema clearance. In contrast, animals
infected with N15A mutant, presented less damaged epithelia and
Na+/K+ ATPase location was not disturbed (Fig. 11B), which
may allow edema resolution, as no accumulation of protein rich
edema was observed under these conditions (Fig. 10).
E protein IC activity triggers the production of IL-1b, TNF
and IL-6, key inflammatory cytokines in lung damage and
edema accumulation
Severe damage caused to the epithelial barrier is associated with
an acute inflammatory response in the lung parenchyma along
Figure 10. SARS-CoV E protein IC activity and lung pathology. Groups of six 16 week-old BALB/c mice were mock infected (Mock) or infected
with 100000 PFU of viruses displaying E protein IC activity (EIC+), either the parental virus (wt) or the genetically engineered revertant viruses V25F
T30I and N15D or with the mutant lacking IC activity (EIC2) N15A. At 2 and 4 dpi 3 mice from each group were sacrificed and their lungs were
collected. (A) Lungs were fixed in formalin, paraffin embedded, sectioned and processed for hematoxylin and eosin staining. Asterisks indicate edema
accumulation in both bronchiolar and alveolar airways. Original magnification was 206. (B) When collected and prior to fixation lungs were weighted.
Error bars indicate the standard deviation from 3 mice lungs per each condition. Statistically significant data are indicated with an asterisk (Student’s
t-test p-value,0.05).
doi:10.1371/journal.ppat.1004077.g010
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with edema accumulation. Elevated levels of inflammatory
cytokines IL-1b, TNF and IL-6 are found in the lungs of ARDS
patients and play a key role in the progression of the disease [62].
IL-1b is an early response highly inflammatory cytokine that is
tightly regulated. During viral infection, recognition of pathogen
molecular associated patterns (PAMPs) by the cells, such as double
stranded viral RNA, induces IL-1b mRNA expression and
translation to generate the inactive form of the protein pro-IL-
1b. Upon certain stimuli, pro-IL-1b is then cleaved by caspase-1
through inflammasome activation, generating the active form IL-
1b, which is subsequently secreted to exert its function [52].
Interestingly, viral proteins with IC activity have been recently
found to activate the inflammasome, which finally leads to the
secretion of active IL-1b to the extracellular media [52,59]. We
thus sought to test whether E protein IC activity was implicated in
the production of active IL-1b in the lungs of SARS-CoV infected
mice. First, the expression of pro-IL-1b mRNA and the amounts
of its derived protein, inactive pro-IL-1b, were measured in wt-
and N15A-infected mice at 2dpi. Infections with both wt and
N15A mutant viruses induced similar overexpression of pro-IL-1b
mRNA as compared with the mock-infected animals (Fig. 12A).
The increased levels of pro-IL-1b mRNA found in infected mice,
Figure 11. Lung epithelia disassembly in SARS-CoV infected BALB/c mice. 16 week-old BALB/c mice were mock infected (Mock) or infected
with 100000 PFU of the parental virus (wt) displaying E protein IC activity or the mutant virus lacking IC activity N15A. At 2 (A) and 4 (B) dpi mice
were sacrificed and their lungs were fixed in formalin, paraffin embedded, sectioned and processed for immunofluorescence. Na+/K+ ATPase was
labeled in green, SARS-CoV N protein was labeled in red to detect infected cells and cell nuclei are shown in blue. A general view of lung epithelia at
an original magnification of 406 is shown in the upper rows of the panels. Magnified bronchiolar epithelia at an original magnification of 1896are
shown in the rows of the bottom. White arrowheads indicate cell desquamation in the bronchiolar barrier. White arrows show epithelium
disassembly and mislocated Na+/K+ ATPase staining away from basolateral cell membranes, and present within air spaces.
doi:10.1371/journal.ppat.1004077.g011
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correlated with enhanced amounts of inactive pro-IL-1b, which
reached similar values in wt and N15A infections (Fig. 12B). To
analyze the levels of active, secreted IL-1b, bronchoalveolar
lavages were performed at 2 dpi. The amount of IL-1b in the
airways was significantly higher in the mice infected with the wt
virus displaying E protein IC activity, over those infected with the
mutant N15A missing this function (Fig. 12C). Collectively, these
data indicated that E protein IC activity promotes the secretion of
mature IL-1b, without increasing pro-IL-1b transcription or
synthesis.
IL-1b enhances the production of TNF, another key early
response cytokine, and IL-6, which follows a more sustained
increase over time [62–64]. Therefore, it is not surprising that both
TNF and IL-6 levels were more dramatically increased in wt-
infected mice in comparison with the N15A-infected mice at 2 dpi
(Fig. 12D and 12E). Furthermore, analysis of IL-6 levels in the
bronchoalveolar lavages of infected mice at 4 dpi, revealed that
overwhelming amounts of this cytokine, exceeding 10000 pg/mL,
accumulated in wt-infected mice, whereas IL-6 levels were at least
2.5-fold lower when E protein IC activity was absent during
infection (Fig. 12E). All these results indicate that the presence of
E protein IC activity correlates with the activation of the
inflammasome and an acute inflammatory response that is
deleterious for lung tissue.
Figure 12. SARS-CoV E protein IC activity and induction of inflammatory cytokines involved in lung injury. Groups of six 16 week-old
BALB/c mice were mock infected or infected with 100000 PFU of the parental virus (wt) displaying E protein IC activity or the mutant virus lacking IC
activity N15A. At 2 dpi 3 mice from each group were sacrificed and their lungs were collected. (A) Total RNA was extracted and levels of pro-IL-1b
mRNA, and 18s rRNA (18S), as a control, were analyzed by RT-qPCR. Error bars indicate the standard deviation from samples of 3 mice per
experimental setting. (B) Lung protein extracts were prepared and levels of inactive pro-IL-1b (35 kDa) and beta-actin, as a loading control, were
detected by Western blot and quantified by densitometry analysis. Bottom of the figure represents the ratio pro-IL-1b/beta-actin relative to the mock-
infected animals levels, as a reference. Bronchoalveolar lavages (BAL) of infected mice were collected and the concentration of (C) the active form of
IL-1b protein at 2 dpi, (D) TNF protein at 2 dpi and (E) IL-6 protein at 2 and 4 dpi within the lavages were determined using the Luminex technology.
Error bars indicate the standard deviation from samples of 3 mice per condition. Discontinuous lines indicate the limit of the detection of the
technique. Statistically significant data are indicated with an asterisk (Student’s t-test p-value,0.05).
doi:10.1371/journal.ppat.1004077.g012
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Discussion
Several viruses that cause severe diseases in humans encode
small transmembrane proteins containing IC activity [44]. The
alteration of host cell ion balance by these proteins is usually
necessary for virus production and maturation, but the effect of IC
activity in pathogenesis is less well understood. Coronaviruses are
the causative agent of recent and likely future serious diseases. We
have focused this study on SARS-CoV E protein, a virulence
determinant displaying IC activity. In this manuscript, we sought
to elucidate the role of E protein IC activity in virus pathogenesis
by combining our knowledge of residues essential for E protein ion
conductivity with the manipulation of SARS-CoV genome. To
this end we used a mouse adapted genetic background (MA15)
assembled in a bacterial artificial chromosome (BAC). Two
rSARS-CoVs, each one containing mutation N15A or V25F in
the transmembrane domain of E protein were generated to knock
down its IC activity. Upon competition during several passages,
the viruses lacking E protein IC activity were clearly overgrown by
the parental virus, which replicated better. Nevertheless, these
differences in viral growth needed several replication cycles to be
amplified and detected, as only slight no significant changes in
virus production were observed after 72 hours growth kinetics. In
agreement with this result, when T16A mutation was introduced
within IBV E protein, which represents the equivalent mutation to
SARS-CoV E protein N15A, no alterations in the production of
virus like particles (VLPs) were detected after 48 hours [40]. The
fact that deeper alterations of CoV E protein transmembrane
domain cause much more dramatic effects in virus production
[37,39] may be due to additional structural or functional changes
in E protein, besides their effect on ion conductivity. In conclusion,
E protein IC activity, although not essential for virus production,
confers and advantage to the virus by enhancing its fitness and
growth. Accordingly, a selective advantage of IC activity has also
been shown for influenza virus. Mutants lacking M2 protein IC
activity were overgrown by the parental virus in competition
assays in an even faster manner than in SARS-CoV, probably
because the influenza virus lacking IC activity has more profound
replication defects [65,66]. SARS-CoV encodes other two
proteins, 3a and 8a, which also contain IC properties [41,42].
Therefore, an essential contribution of IC activity to virus
production cannot formally be excluded for SARS-CoV, as 3a
and 8a derived ion channels could functionally compensate the
absence of E protein IC activity.
SARS-CoV mutant viruses lacking E protein IC activity showed
a clear tendency to revert both in cell culture and in vivo after mice
infection. N15A and V25F mutant viruses, devoid of E protein ion
conductivity, incorporated additional mutations in the E gene to
restore IC activity, suggesting that this function confers a selective
advantage to the virus. This trend was more evident in the case of
V25F virus, which evolved more quickly and frequently than the
N15A mutant virus. No reversion of E protein IC activity was
observed for N15A mutant in mice, at least during the first five
days post infection. Attempts to sequence the viral progeny at 9
and 10 days after the inoculation were unsuccessful, probably
because the virus was mostly cleared by those time points.
Nevertheless, as N15A mutant restored its ion channel activity
after long number (.24) of passages in cell culture, it is possible
that after serial passages in vivo this mutant could also revert, as ion
conductivity confers better fitness for the virus. Although both
N15A and V25F mutations equally disrupted IC activity, the
mechanisms by which this is achieved could be different.
Replacement of N at position 15 to A, an amino acid predicted
to be located facing the channel lumen, is not likely to affect the
channel architecture. In fact, the rotational orientation in lipid
bilayers of a labeled synthetic transmembrane peptide bearing this
mutation was entirely consistent with that of a pentameric model
[29]. In contrast, mutation at V25 implies the introduction of a
larger side chain (replacement of V to F) at the monomer-
monomer interface, which is likely to affect the overall structure of
the homo-oligomer and therefore inhibit ion conductivity by
causing larger structural changes. This may also explain the higher
number of compensatory mutations found in V25F with respect to
N15A virus, as the ways to recover a stable oligomer are more
varied than those needed to recover channel activity. The
compensatory mutations incorporated by the V25F mutant
mapped to the opposite face of the transmembrane helix, although
they are adjacent when the E protein pentamer is formed.
Therefore, the compensatory mutations most likely restored the
interaction and assembly between the mutated monomers,
reinforcing our hypothesis (Fig. 6). IC activity restoration through
virus passage suggests that this function is important for the virus.
Several of the mutations restoring ion channel activity appeared
both in mice and in cell culture. Therefore, it seems that reverting
E protein ion conductivity, and not adaptation to mice, was its
main goal. Nevertheless, the possibility that these mutations could
also improve mouse adaptation through an ion channel dependent
or independent mechanism cannot be fully excluded.
E protein IC activity was also involved in SARS-CoV
pathogenesis as tested in the mouse model. Viruses lacking IC
activity that were stable during multiple passages (N15A mutants)
caused reduced mortality, whereas the wt and the mutant viruses
restoring IC activity during mice infection (V25F background-
evolved variants) caused high mortality rates. Furthermore,
genetically engineered viruses containing the point mutations
necessary to recover E protein IC activity induced similar
mortality as wt virus, reinforcing that E protein IC activity
contributes to SARS-CoV pathogenicity. The relevance of
viroporins in virus virulence has also been shown in other viruses,
such as respiratory syncytial virus SH protein, influenza A virus
M2 protein and classical swine fever virus p7 protein [67–70], by
deleting a large fraction of or the entire protein. Viroporins may
play other critical functions apart from ion conduction. Therefore,
a direct correlation between IC activity and virulence could not be
formally established. To our knowledge, this is the first time in
which the IC activity of a viroporin is directly linked to the
virulence of the virus.
The infection with highly pathogenic respiratory viruses,
including SARS-CoV, is one of the causative agents of acute lung
injury (ALI) and its most severe form, ARDS [71]. Just in the
United States, 200,000 ARDS cases are reported annually with a
40% mortality rate [72]. Late stages of ARDS are characterized by
development of pulmonary edema that leads to an impaired gas
exchange, hypoxemia and eventually death. Infection of mice with
rSARS-CoV-MA15 resulted in an abundant edema accumulation
both in alveolar and bronchiolar spaces at late times post infection
(4 dpi), which correlated with mortality. This phenotype was
reproduced upon mice infection with other highly-virulent SARS-
CoVs displaying IC activity based on alternative E protein
sequences (revertant viruses). On the other side, infection of mice
with the attenuated mutant lacking E protein IC activity (N15A)
caused significantly reduced edema accumulation, likely contrib-
uting to a majority of the animals surviving. Collectively, these
data indicate that E protein IC activity in vivo promotes lung
pathology through edema accumulation.
The pulmonary epithelia regulate water levels present within air
spaces, a critical parameter for gas exchange, and play a critical
role in edema clearance [72,73]. Epithelial cells create an osmotic
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gradient mainly through a coordinated Na+ transport first from
the airways to the cell cytoplasm through epithelial sodium
channels (ENaC), located at the apical part of the plasma
membrane, and then to the interstitium by Na+/K+ ATPase,
present at the basolateral region of the plasma membrane. This
vectorial transport of Na+ is accompanied by a water removal
from the airspace and edema resolution [72,73]. The integrity of
alveolar and bronchiolar epithelia was analyzed by labeling of
Na+/K+ ATPase in the lungs of mice infected with the virus
containing or lacking IC activity. Interestingly, animals infected
with the wt virus presented a strong disassembly of bronchiolar
epithelia and mislocalization of Na+/K+ ATPase from its
basolateral distribution within cells at late times, coincident with
edema accumulation. In contrast, epithelia integrity was clearly
preserved in the lungs of animals infected with the virus missing E
protein IC activity. Intact lung epithelia may be required for
proper function of the main components involved in edema
resolution (Na+/K+ ATPase and ENaC), which may explain the
lack of edema and therefore the attenuation observed for this virus.
As previously described for SARS-CoV, differences in viral
tropism within lung cells, without affecting viral production, can
induce different pathologies [74]. Nevertheless, we have observed
no significant differences in the infection patterns in the presence
or absence of E protein ion channel activity, suggesting that the
virulence conferred by E protein IC activity does not depend on
alternative tropisms.
Pulmonary epithelia damage leading to ALI and ARDS is a
consequence of a cytokine burst initiated, in this case, by viral
infection. One of the key early-response cytokines driving
proinflammatory activity in bronchoalveolar spaces is IL-1b
[75]. IL-1b is mainly produced by macrophages and dendritic
cells through inflammasome activation. Ion imbalances within
cells have been described as triggers of this pathway [52]. The
levels of active IL-1b secreted to the airways were enhanced when
E protein IC activity was conserved in SARS-CoV infection.
Taking into account that the presence or absence of SARS-CoV E
protein IC activity did not interfere with the production of IL-1b
precursors (mRNA and protein levels of pro-IL-1b), these results
suggest that E protein ion conduction may induce inflammasome
triggering resulting in secretion of mature IL-1b. In agreement
with this hypothesis, release of active IL-1b has recently been
reported for viroporins of other viruses [52,53,57,59]. IL-1b is
implicated in the development of diverse pathologies, including
obesity, atherosclerosis, diabetes and several pulmonary illnesses
such as asthma, pulmonary obstructive chronic disease and ARDS
progression through edema accumulation [75–78]. Here, we
report the implications of this cytokine in SARS-CoV pathology
and E protein ion channel activity as a trigger of its production.
ARDS progression involves the production of TNF, another
early response cytokine, and IL-6, which exerts its function in a
more sustained manner accumulating during the disease [63]. We
found that after SARS-CoV infection, these patterns of cytokine
expression were clearly reproduced. TNF and IL-6 accumulated
to higher levels in the lungs of animals infected with the wt virus
displaying IC activity compared to the mutant lacking ion
conductivity. IL-1b enhances the production of TNF, and IL-6
is stimulated by both cytokines providing an integrated amplified
inflammatory response, detrimental for pulmonary function [63].
Elevated amounts of these cytokines have been reported in
bronchoalveolar lavages of SARS-CoV patients [79]. Therefore,
the enhanced amounts of active IL-1b found in the animals
infected with the wt virus may explain the increased levels of TNF
and IL-6, which leads to severe pathology. It is important to note
that the increased damage found in pulmonary epithelia infected
with the virus displaying E protein IC activity may not be
explained by a higher virus production, as suppression of E protein
IC activity rendered similar growth in mice lungs during the
analyzed time points. SARS-CoV early replication may be a
relevant issue in the induction of pathology. We cannot exclude
early replicative defects for the N15A mutant in mice, delaying
virus growth during the first hours post-infection. Nevertheless,
alternative explanations are also possible, as it has been described
that some mutations at SARS-CoV S gene conferred increased
virulence without affecting growth within mice, even at early
times. This increased pathogenesis was mainly dependent on an
exacerbated host response to the viral infection [74]. Accordingly,
the enhanced inflammatory response triggered by E protein ion
channel proficient viruses may be a major pathology inducer.
In this study, we have shown that SARS-CoV E protein IC
activity is a virulence determinant, influencing inflammatory
responses, including those inflammasome-derived, pulmonary
damage and disease outcome. Although not essential for virus
production, E protein IC activity confers a selective advantage, as
the parental virus, competent for ion conductivity, was more fit.
Nevertheless, the virulence associated to E protein ion conductivity
could represent a non-selectable consequence. SARS-CoV crossed
species barriers from zoonotic reservoirs such as bats, palm civets
and raccoon dogs to humans, causing a severe disease [71].
Possibly, in SARS-CoV infection of its natural hosts, E protein ion
channel activity may not have a relevant impact in SARS-CoV
pathogenesis, and therefore it was positively selected before
crossing species barrier. In conclusion, this work provides several
findings that may have translational relevance for other corona-
viruses, such as the highly pathogenic MERS-CoV, and even on
other viruses encoding proteins with IC activity.
Materials and Methods
Ethics statement
Animal experimental protocols were approved by the Ethical
Committee of The Center for Animal Health Research (CISA-
INIA) (permit numbers: 2011-009 and 2011-09) in strict accor-
dance with Spanish national Royal Decree (RD 1201/2005) and
international EU guidelines 2010/63/UE about protection of
animals used for experimentation and other scientific purposes and
Spanish national law 32/2007 about animal welfare in their
exploitation, transport and sacrifice and also in accordance with
the Royal Decree (RD 1201/2005). Infected mice were housed in
a ventilated rack (Allentown, NJ).
Cells
The African green monkey kidney-derived Vero E6 cells were
kindly provided by Eric Snijder (Medical Center, University of
Leiden, The Netherlands). The mouse delayed brain tumor cells
stably expressing the murine receptor for SARS-CoV (DBT-
mACE2) were generated as previously described [61]. Baby
hamster kidney cells (BHK-21) were obtained from American
Type Culture Collection (ATCC; CCL-10). Cells were grown at
37uC with an atmosphere of 98% humidity, in Dulbecco’s
modified Eagle medium (DMEM, GIBCO) supplemented with
25 mM HEPES, 2 mM L-glutamine (SIGMA), 1% non essential
amino acids (SIGMA) and 10% fetal bovine serum (FBS,
Biowhittaker).
Mice
Specific-pathogen-free 8 week-old BALB/c OlaHsd female
mice were purchased from Harlan. Mice were maintained for 8
additional weeks in the animal care facility at the National Center
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of Biotechnology (Madrid). All protocols were approved by the
Ethical Review Committee at the center for animal health
research (CISA-INIA). For infection experiments, 16-week-old
mice females were anesthetized with isoflurane and intranasally
inoculated with 100000 PFU of the indicated viruses. All work
with infected animals was performed in a BSL3 laboratory (CISA,
INIA) equipped with a ventilated rack (Animal transport unit-Bio
containment unit, Harvard) to store the animals during the
experiment.
Construction of mutant rSARS-CoVs-MA15
An infectious cDNA clone encoding a mouse adapted (MA15)
SARS-CoV assembled in a bacterial artificial chromosome (BAC)
in our laboratory [26] was used as the background to introduce the
mutations that inhibited or restored E protein IC activity. Briefly,
DNA fragments representing the nucleotides 26044 to 26779 of
SARS-CoV-MA15 genome, flanked by the restriction sites BamHI
and MfeI, respectively, were chemically synthesized (Bio Basic
Inc). These fragments contained different point mutations within
the E gene, that generated amino acid changes inhibiting IC
activity: N15A (AAT to GCC) and V25F (GTA to TTC) or
restoring this activity: N15D (GCC to GAC), V25F L19A (GTA to
TTC and CTT to GCA), V25F L27S (GTA to TTC and TTG to
TCG), V25F T30I (GTA to TTC and ACA to ATA), V25F L37R
(GTA to TTC and CTT to CGT). The fragments containing these
mutations were digested and exchanged in the original BAC. The
genetic integrity of the cloned DNA was verified by restriction
analysis and sequencing.
Recovery of recombinant viruses from the cDNAs clones
BHK cells were grown to 95% confluency in 12.5 cm2 flasks
and transfected with 6 mg of the infectious cDNA clones and 18 ml
of Lipofectamine 2000 (Invitrogen), according to the manufactur-
er’s specifications. At 6 hours post transfection, cells were
trypsinized, added to Vero E6 cells confluent monolayers grown
in 12.5 cm2 flasks and incubated at 37uC for 72 h. Cell
supernatants were harvested, passaged once on fresh cells and
the recovered viruses were cloned by three rounds of plaque
purification following standard procedures.
Growth kinetics and plaque assays
Vero E6 or DBT-mACE2 cells were grown to confluency on
12.5 cm2 flasks and infected at a multiplicity of infection (MOI) of
0.001. Cells supernatants were collected at 0, 6, 24, 48 and 72 hpi
and titrated on Vero E6 cells. For virus titration and plaque
detection, supernatants of infected cells were added to confluent
monolayers of Vero E6 cells and incubated for 45 min at 37uC.
Media was removed and cells were overlaid with DMEM
containing 0.6% of low melting agarose and 2% of fetal calf
serum (FCS). At 72 hpi cells were fixed with 10% formaldehyde
and stained with crystal violet.
Confocal microscopy
Vero E6 cells were grown to 90% confluency on glass coverslips
and infected with rSARS-CoV-DE, rSARS-CoV wt, rSARS-CoV-
E-N15A and rSARS-CoV-E-V25F at an MOI of 0.3. At the
indicated hpi, media were removed and cells were washed twice
with PBS and fixed with 4% paraformaldehyde in PBS for 30 min
at room temperature. Then, cells were washed twice with PBS and
permeabilized for 10 min with 0.2% saponin and 10% FBS in
PBS. Primary antibody incubations were performed in PBS
containing 10% FBS and 0.2% saponin for 1 h 30 min at room
temperature. Immunofluorescence was performed using a mouse
mAb specific for ERGIC53 (dilution 1:200, Alexis Biochemicals),
and a rabbit pAb specific for E protein [15] at 1:2000 dilution.
Coverslips were washed four times with PBS between primary
and secondary antibody incubations. Alexa 488- or Alexa 546-
conjugated antibodies specific for the different species (dilution
1:500, Invitrogen) were incubated for 45 min at room temper-
ature in PBS containing 10% FBS. Nuclei were stained using
DAPI (dilution 1:200, Sigma). Coverslips were mounted in
ProLong Gold anti-fade reagent (Invitrogen) and examined on a
Leica SP5 confocal microscope (Leica Microsystems). Colocali-
zation studies were performed using Leica LAS AF v2.6.0
software.
Virus genome sequencing
The genomic region including nucleotides 26017 to 26447 that
contains the E gene was sequenced after RT and PCR reactions.
Briefly, total RNA from infected cells or homogenized mice lungs,
was collected and purified using RNeasy kit (Qiagen) according to
the manufacturer’s specifications. For RT reaction, 1 mg of RNA
was used as template, random oligonucleotides primers and
Thermoscript reverse transcriptase (Invitrogen). The product was
subsequently subjected to a PCR reaction using the oligonucle-
otides E-VS (CTCTTCAGGAGTTGCTAATCCAGCAATGG)
and E-RS (TCCAGGAGTTGTTTAAGCTCCTCAACGGTA)
and the Vent polymerase (New England Biolabs), following
manufacturer’s recommendations. Sequence assembly and com-
parison with the consensus sequence of SARS-CoV-MA15 strain
were performed with the SeqMan program (Lasergene, Madison,
WI).
Genetic stability through serial infections of SARS-CoVs
lacking IC activity
Confluent monolayers of Vero E6 cells grown in 12.5 cm2 flasks
were infected at an MOI of 0.5 with the viruses rSARS-CoV wt,
rSARS-CoV-E-N15A and rSARS-CoV-E-V25F. At 24 hpi,
supernatants were collected and passaged on fresh monolayers of
Vero E6 cells, performed 24 times, serially. E gene sequence was
analyzed at passages 0, 8, 16 and 24 as described.
For in vivo experiments, mice were intranasally inoculates with
100000 PFU of the viruses described above. Lungs were
collected at days 2 and 4 post infection and incubated in
RNAlater (Ambion) at 4uC for 48 hpi prior to 280uC freezing.
To extract total RNA, lungs were homogenized in 2 ml of RLT
lysis buffer (QIAGEN) containing 1% b-mercaptoethanol using
gentleMACS Dissociator (Miltenyi Biotec). Samples were
centrifuged at 3000 rpm during 10 min, and RNA was purified
from supernatants using RNeasy kit (QIAGEN) as previously
described.
Peptide synthesis and ion channel measurements in
artificial lipid membranes
Synthetic peptides representing the transmembrane domain of
SARS-CoV E protein (amino acids 7 to 38) encoding the point
mutations that appeared after serial infections of the mutant
viruses were generated by standard phase synthesis, purified by
HPLC and their IC activity was tested in artificial lipid
membranes, as previously described [34].
Competition assays
Total RNA from co-infected cells was isolated and E gene was
sequenced as described above. Relative abundance of the rSARS-
CoV wt and rSARS-CoV-E-N15A viruses within viral population
was determined by quantifying the relative amounts of their
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respective E gene genetic markers in the sequence obtained from
the population.
Mice infection and evaluation of virus virulence
16 week-old BALB/c mice females were intranasally inoculated
with 100000 PFU of the viruses rSARS-CoV wt, rSARS-CoV-E-
N15A, rSARS-CoV-E-V25F, rSARS-CoV-E-N15D, rSARS-
CoV-E-V25F L27S, rSARS-CoV-E-V25F T30I and rSARS-
CoV-E-V25F L37R in 50 ml of DMEM containing 2% FCS.
Weight loss and survival of the infected mice were monitored for
10 days. Animals reaching weight losses higher than 25% of the
initial body weight were sacrificed according to the established
euthanasia protocols.
Virus growth in mice lungs and lung histology
Mice were inoculated with 100000 PFU of the virus rSARS-
CoV wt, rSARS-CoV-E-N15A, rSARS-CoV-E-N15D and
rSARS-CoV-E-V25F T30I, sacrificed at days 2 and 4 post
infection, and lungs were collected. To analyze viral growth,
right lungs were homogenized in 2 ml of Phosphate Buffered
Saline (PBS) containing 100 UI/ml penicillin, 100 mg/ml
streptomycin, 50 mg/ml gentamicin and 0.5 mg/ml fungizone
using MACS homogenizer (Miltenyi Biotec) according to
manufacturer’s protocols, and titered as previously described.
To examine lung histopathology, left lungs of infected mice
were incubated with 10% zinc formalin for 24 h at 4uC,
embedded in paraffin, sectioned, and stained with hematoxylin
and eosin.
Immunofluorescence in lung sections
Five micron sections of zinc formalin fixed lungs were
deparaffined at 60uC and rehydrated by successive incubations
in 100% xylol, 100% ethanol and 96% ethanol. Antigen unmask
was performed by boiling the samples in citrate buffer (8.2 mM
sodium citrate; 1.8 mM citric acid, pH 6.5) for 5 min at 110uC in
a decloaking chamber (Biocare medical). Samples were then
permeabilized with 0.25% Triton X-100 in PBS for 15 min and
blocked with 10% bovine serum albumin (BSA) and 0.25% Triton
X-100 in PBS for 30 min. Samples were labeled with a mouse
monoclonal antibody specific for SARS-CoV N protein (kindly
provided by Ying Fang, South Dakota State University) diluted
1:250 and a rabbit monoclonal antibody specific for Na+/K+
ATPase alpha subunit (Abcam) diluted 1:100 in 0.25% Triton X-
100 and 10% BSA in PBS for 1 h 30 min at room temperature.
Goat anti-mouse and goat anti-rabbit secondary antibodies bound
to Alexa 488 and Alexa 594 fluorophores were used respectively at
a dilution 1:250 in 0.25% Triton X-100 and 10% BSA in PBS for
45 min at room temperature. Cell nuclei were stained with DAPI
(1:200). Tissues were mounted in ProLong antifade reagent
(Invitrogen) and analyzed in a Leica TCS SP5 confocal
microscope.
RT-qPCR analysis
RNA extracted from lungs of infected mice was prepared as
described above, and subjected to retro transcriptase reactions
using a High-Capacity cDNA transcription kit (Applied Biosys-
tems) to generate cDNAs. PCR using Taqman assays specific for
IL-1b (Mm01336189-m1) and 18S ribosomal RNA as a control
(Mm03928990-g1) [80,81] (Applied Biosystems) were performed.
Data were acquired with an ABI Prism 7000 sequence detection
system (Applied Biosystems) and analyzed using ABI Prism 7000
SDS v1.0 software. Gene expression relative to mock-infected
samples is shown.
Lung protein extracts preparation and western blot
assays
Lungs from infected mice were collected at 2 dpi and the right
lung was homogenized in 1.2 mL of protein lysis buffer containing
Tris/HCl 10 mM, EDTA 1 mM, NaCl 150 mM, IGEPAL 1%,
and complete protease inhibitor (Roche) pH8, using MACS
homogenizer (Miltenyi Biotec). Samples were centrifuged for 1 h
at 4uC and 130006g and supernatants were collected. Pro-IL-1b
levels were analyzed by Western blotting using a goat anti mouse
IL-1b/IL-1F2 antibody (R&D systems). As a loading control, beta-
actin was labeled using a mouse monoclonal antibody (Abcam).
Bound antibodies were detected using a rabbit anti goat and a
rabbit anti mouse HRP conjugated antibodies and the Immobilon
Western chemiluminiscence substrate (Millipore), following man-
ufacturer’s specifications. Densitometric analysis was performed in
non-saturated exposures of several experimental replicates using
Quantity One, version 4.5.1 software (BioRad). Levels of pro-IL-
1b were normalized to the levels of beta-actin.
Bronchoalveolar lavages
Following euthanasia by cervical dislocation, the trachea was
exposed and cannulated through the animal mouth with a 19
gauge tube. Lungs were lavaged three times with 400 ml of cold
phosphate buffered saline (PBS). Samples were centrifuged for
10 minutes at 30006 g at 4uC to separate cellular content, and
supernatants were collected to analyze their cytokine levels.
Cytokine multiplex analysis
Bronchoalveolar lavages were treated with IGEPAL reaching a
final concentration of 0.2%, to inactivate sample infectivity. The
expression of IL-1b, TNF and IL-6 was measured using Luminex
technology and a mouse cytokine antibody bead kit (Milliplex map
kit, Millipore) according to the manufacturer’s specifications.
Supporting Information
Figure S1 Infection efficiency and cellular tropism
within mice lungs, in the presence or absence of SARS-
CoV E protein IC activity. 16 week-old BALB/c mice were
infected with 100000 PFU of the parental virus (wt, black
columns) displaying E protein IC activity or the mutant virus
lacking IC activity N15A (red columns). At 2 and 4 dpi mice were
sacrificed and their lungs were fixed in formalin, paraffin
embedded, sectioned and processed for immunofluorescence.
SARS-CoV N protein and cell nuclei were labeled to discriminate
both non-infected and infected cells. The number of alveolar
(alveo), bronchiolar (bronch) and overall infected cells (total) were
calculated in several representative images, and represented as
percentages of their corresponding total cells (infected plus non-
infected). Error bars indicate the standard deviation from the data
collected from different images.
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